X
US blood pressure drug price doubles following shortages
https://pharmaphorum.com/news/us-blood-pressure-drug-price-doubles-following-shortages/
cardiology
NHS England okays funding for cholesterol-lowering drug
Lojuxta will be available to patients this year
Amgen’s Repatha gets EU cardio risk reduction label
But Sanofi/Regeneron could have advantage thanks to price cut and better data
EU approves AZ’s potential blockbuster hyperkalaemia drug
After manufacturing issues, AstraZeneca hopes for FDA nod soon.
Digital health round-up: Could Nokia kill off digital health unit?
Richard Staines gives a round-up of the latest developments in digital health over the last week.
